Article

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data

2025-02-13

Abstract excerpt

Vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generates an antibody response that shows large inter-individual variability. This variability complicates the use of antibody levels as a correlate of protection and the evaluation of population- and individual-level infection risk without access to broad serological testing. Here, we applied a mathematical model of antibody kine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 39202f5f-0429-55aa-a5ea-4d2f4c80bd3a
DOI: 10.1101/2025.02.10.25322008

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataDOI 10.1101/2025.02.10.25322008Read

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjectsSemantic proximity Read

Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2Semantic proximity Read

Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19Semantic proximity Read

Insights into B Cell and Antibody Kinetics Against SARS-CoV-2 Variants Using Mathematical ModellingSemantic proximity Read

Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort StudySemantic proximity Read

A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of diseaseSemantic proximity Read

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunitySemantic proximity Read

Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severitySemantic proximity Read

Mechanistic models of humoral kinetics following COVID-19 vaccinationSemantic proximity Read

Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2Semantic proximity Read

Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19Semantic proximity Read

Longitudinal proteomic investigation of COVID-19 vaccinationSemantic proximity Read